Aman Khera (Worldwide Clinical Trials)

article

Clinical trial trends – what will 2022 bring?

Here, EPR’s Hannah Balfour examines the trends that look set…

2 February 2022 | By Hannah Balfour (European Pharmaceutical Review)

Here, EPR’s Hannah Balfour examines the trends that look set to shape clinical research in 2022, with comment from Aman Khera, VP and Global Head of Regulatory Strategy at Worldwide Clinical Trials.

article

Making use of those ‘in the know’

In this article, Aman Khera, the Global Head of Regulatory…

28 June 2021 | By Hannah Balfour (European Pharmaceutical Review)

In this article, Aman Khera, the Global Head of Regulatory Strategy for Worldwide Clinical Trials, makes a case for regulatory involvement in drug development from start to finish and explains how the role of the regulator is changing, as well as what this means for pharma.